Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Compounding fills that gap
The main rationale for cycling rather than continuous use involves conservative safety practices given limited long-term human data, cost management, and theoretical concerns about receptor desensitization with extended exposure
If ample copper 2+ is available in a test system or an animal, GHK should easily obtain necessary copper
My expectations were high and they went above and beyond to not only make the process easy but also to make me feel comfortable from the moment I stepped in to the moment I left! Reggie H